Service de Chirurgie, Institut Jules Bordet, Université Libre de Bruxelles, 121 Boulevard de Waterloo, 1000, Brussels, Belgium.
Service d'Oncologie, CHU Ambroise Paré, 2 Boulevard Kennedy, 7000, Mons, Belgium.
World J Surg Oncol. 2018 Mar 7;16(1):48. doi: 10.1186/s12957-018-1346-1.
The development of a second primary tumor is a potential late side effect of radiotherapy. Particularly, an increased risk of secondary cancers, mostly of digestive or breast origin, has been observed in patients treated with high-dose radiotherapy for Wilms tumor (WT) in childhood. However, hepatocellular carcinoma (HCC) has been very rarely described as a potentially radiotherapy-induced tumor. We describe the case of a patient with an aggressive HCC 50 years after the treatment of a WT.
A 49-year old man, treated at the age of 6 weeks for a right WT by a right nephrectomy and adjuvant radiotherapy, presented with a right abdominal mass. Imaging demonstrated a 100-mm tumor invading the inferior segment of the right liver, the right colon and the right psoas muscle. The patient had no previous history of liver disease, nor of alcohol consumption, and hepatitis serologies were negatives. Biopsy demonstrated a poorly differentiated tumor of unknown origin. A panel of tumor markers was negative. Explorative surgery has been performed allowing en bloc R0 tumor resection, including resection of segments VI and VII of the liver, right hemicolectomy and resection of the anterior sheet of the right psoas muscle. Pathological examination revealed a poorly differentiated HCC. No signs of cirrhosis or chronic liver disease were observed in the non-tumor liver. Twenty weeks after surgery, the patient developed a multifocal tumor recurrence that was treated with intra-arterial Yttrium radioembolization.
In this case, the absence of risk factors for HCC, such as cirrhosis, viral hepatitis and chronic liver disease, highly suggests the development of HCC to be related to previous high-dose radiation therapy given for a right WT to a field involving the inferior part of the liver. This observation shows radiotherapy to/near the liver, particularly in childhood, to be a potential risk factor for HCC, stressing the need for a long-term specific follow-up in patients irradiated in childhood.
发生第二原发肿瘤是放疗的一种潜在晚期副作用。特别是,在儿童期接受大剂量放疗治疗 Wilms 瘤(WT)的患者中,观察到继发癌症(主要来自消化道或乳腺)的风险增加。然而,肝癌(HCC)作为一种潜在放疗诱导的肿瘤非常罕见。我们描述了一名患者在接受 WT 治疗 50 年后患有侵袭性 HCC 的病例。
一名 49 岁男性,6 周大时因右侧 WT 接受右侧肾切除术和辅助放疗治疗,因右侧腹部肿块就诊。影像学检查显示 100mm 大小的肿瘤侵犯右肝下段、右结肠和右腰大肌。患者既往无肝脏疾病史,也无饮酒史,肝炎血清学检查均为阴性。活检显示为来源不明的低分化肿瘤。一组肿瘤标志物为阴性。手术探查可进行整块 R0 肿瘤切除,包括肝 VI 段和 VII 段、右半结肠和右腰大肌前叶切除术。病理检查显示为低分化 HCC。非肿瘤肝未见肝硬化或慢性肝病的迹象。手术后 20 周,患者出现多灶性肿瘤复发,采用动脉内钇放射性栓塞治疗。
在这种情况下,HCC 的风险因素(如肝硬化、病毒性肝炎和慢性肝病)缺失,强烈提示 HCC 的发生与先前接受的右 WT 治疗相关,治疗场涉及肝脏的下部。这一观察结果表明,放疗至/靠近肝脏,特别是在儿童期,是 HCC 的一个潜在危险因素,强调了在儿童期接受放疗的患者需要进行长期的特定随访。